Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase III trial of LY06006 in postmenopausal osteoporosis at high fracture risk
ChiCTR2000032882Phase 3Recruiting
- Sponsor
- Shanghai Sixth People's Hospital
- Start
- Jun 2020
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of CMAB807 in osteoporosis (2 arms), sponsored by Shanghai Sixth People's Hospital. Primary endpoint: Change rate of lumbar spine bone mineral density from baseline at 12 months. Started Jun 2020; status: recruiting.
02
Drugs
CMAB807
03
Conditions
osteoporosis
Beyond the preview
Go deeper on ChiCTR2000032882.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2000032882.